alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
R18 - 2 - 205. Nitrogen Oxides (Nitrogen Dioxide)

A. The primary ambient air quality standards for oxides of nitrogen, measured in the ambient air as nitrogen dioxide, are: 1. 53 parts per billion - annual average concentration. 2. 100 parts per billi on - one - hour average concentration. B. The secondary ambient air quality standard for nitrogen dioxide is 0.053 (parts per million (100 micrograms per cubic mete r) -

- annual arithmetic mean. C. The levels of the standards shall be measured by a reference method based on 40 CFR 50, Appendix F or a federal equivalent method designated in accordance with 40 CFR 53. D. The annual primary standard is met when the annual average concentration in a calendar year is less than or equal to 53 pp b, as determined in a ccordance with 40 CFR, Appendix S for the annual standard. E. The one - hour primary standard is met when the three - year average of the annual 98th percentile of the daily maximum one - hour average concentration is less than or equal to 100 parts per billion, as determined in accordance with 40 CFR 50, Appendix S. F. The secondary standard is attained when the annual arithmetic mean concentration in a calendar year is less than or equal to 0.053 ppm, rounded to three decimal places, with fractional parts equal to or greater than 0.0005 ppm rounded up. To demonstrate attainment, an annual mean shall be based upon hourly data that is at least 75% complete or upon data derived from the manual methods, that is at least 75% complete for the scheduled sampling days i n each calendar quarter. Historical Note Amended effective December 22, 1976 (Supp. 76 - 5). Former Section R9 - 3 - 206 repealed, new Section R9 - 3 - 206 adopted effective May 14, 1979 (Supp. 79 - 1). Amended effective October 2, 1979 (Supp. 79 - 5). Amended effective August 29, 1980 (Supp. 80 - 4). Amended by deleting subsections (B) through (D) effective September 22, 1983 (Supp. 83 - 5). Former Section R9 - 3 - 206 renumbered without change as Section R18 - 2 - 206 (Supp. 87 - 3). Former Section R18 - 2 - 205 renumbered to R18 - 2 - 204, new Section R18 - 2 - 205 renumbered from R18 - 2 - 206 and amended effective September 26, 1990 (Supp. 90 - 3). Amended by final rulemaking at 18 A.A.R. 1542, effective August 7, 2012 (Supp. 12 - 2).
EXHIBIT 32.01

DEER VALLEY CORPORATION

CERTIFICATION PURSUANT TO RULE 13a-14(b) OR RULE 15d-14(b) OF THE

SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with this quarterly report on Form 10-Q for the quarter ended September 30, 2008 of Deer Valley Corporation (the Company), as filed with the Securities and Exchange Commission on the
date hereof (the Report), I, Charles G. Masters, President and Chief Executive Officer of the Company, certify pursuant to Rule 13a-14(b) or 15d-14(b) of the Securities and Exchange Act of 1934, as adopted pursuant to Section 906 of
the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:



| | 1. | the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
| | -- | ---------------------------------------------------------------------------------------------------------------------------------



| | 2. | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| | -- | ----------------------------------------------------------------------------------------------------------------------------------------------------



|                                     
|-------------------------------------
|/s/    Charles G. Masters            
|Charles G. Masters                   
|President and Chief Executive Officer
|November 14, 2008
IN THE UNITED STATES DISTRICT COURT

FOR THE WESTERN DISTRICT OF TEXAS

AUSTIN DIVISION

BRYNNE SOUKUP, §

§

Plaintiff, §

§

v. § Civil Action No. 1:20-cv-648

§

FRONTIER AIRLINES, INC., §

§

Defendant. § 

CERTIFICATE OF INTERESTED PERSONS

Pursuant to Fed. R. Civ. P. 7.1 and LR 3.1(c), LR 3.2(e), LR 7.4, LR 

81.1(a)(3)(D), and LR 81.2, Plaintiff, BRYNNE SOUKUP, provide the following 

information:

For a nongovernmental corporate party, the name(s) of its parent corporation 

and any publicly held corporation that owns 10% or more of its stock (if none, 

state "None"): 

Frontier Airlines Holdings (NASDAQ Symbol = “FRNT”)

Frontier Airline Holdings, Inc. (NASDAQ Symbol = “FRNTQ”)

A complete list of all persons, associations of persons, firms, partnerships, 

corporations, guarantors, insurers, affiliates, parent or subsidiary corporations, or 

other legal entities that are financially interested in the outcome of the case: 

BRYNNE SOUKUP, Plaintiff.

TRENTON N. LACY, CHARLES L. SCALISE, ESQ., DANIEL B. ROSS, ESQ., 

ROSS • SCALISE LAW GROUP, Attorneys for Plaintiff.

FRONTIER AIRLINES, INC, Defendant;

FLIGHT SERVICE & SYSTEMS, LLC.

Dated: June 21, 2020.

Case 1:20-cv-00648-RP Document 2 Filed 06/21/20 Page 1 of 2
Respectfully submitted,

/s/ Daniel B. Ross

DANIEL B. ROSS

Attorney-in-Charge 

Texas Bar No. 789810

CHARLES L. SCALISE

Texas Bar No. 24064621

TRENTON N. LACY

Texas Bar No.: 24106176

(Admission Pending)

ROSS • SCALISE LAW GROUP

Texas Bar No. 00789810

1104 San Antonio Street

Austin, Texas 78701

(512) 474-7677 Telephone

(512) 474-5306 Facsimile

Trenton@rosslawgroup.com

dan@rosslawgroup.com

ATTORNEYS FOR PLAINTIFF

Case 1:20-cv-00648-RP Document 2 Filed 06/21/20 Page 2 of 2
From: "Teresa S. Bowers" <TBOWERS@gradientcorp.com>

To: Nathan Topham/RTP/USEPA/US@EPA

Cc: "Stotts, Stacy" <SStotts@stinson.com>, "Marucheau, Louis" <lmarucheau@doerun.com>,

"'Miller, Aaron'" <amiller@doerun.com>, Joe Stolle <joseph@shellengr.com>

Date: 03/30/2011 01:25 PM Subject

: Doe Run property ownership map

Nate, Attached is the Doe Run property ownership map that I showed in the meeting yesterday.

Terri

--- Teresa S. Bowers, Ph.D. | Principal 617-395-5524 | tbowers@gradientcorp.com

Gradient | 20 University Road | Cambridge, MA 02138 | 617-395-5000 | www.gradientcorp.com

This message contains information which may be confidential or privileged. Unless you are the addressee (or authorized to receive for the addressee), you may not use, copy, or disclose to anyone this message or any information contained in the message. If you have received this message in error, please advise the sender by reply e-mail, and delete all copies of this message and its attachment(s).

Page 1Ap

Project No.: xxxxxx; PM: xxx; Drawn By: mkovach; Checked By: xxx; Coordinate System: NAD 1983 StatePlane Missouri East FIPS 2401 Feet; Path: G:\Projects\202022-DoeRun\Graphics\CADGIS\101\202022-101_05_VPP_Changes.mxd;FIGURE5Date: 3/30/2011GradientDoe Run Propertiesowned in 2009Herculaneum, MissouriLEGENDAFacilityVPP AreaOne Mile RadiusDoe Run Properties 200901,000500Feet
2:20

cv

24
Exhibit 21.1
  List of
    subsidiaries of the Registrant
  Subsidiary

JurisdictionCavium Networks International, Inc.

DelawareCavium International

CaymanCavium Networks International

CaymanCavium Networks (India) Private Limited

IndiaCavium Networks Asia

CaymanCavium Networks U.K. Limited

EnglandCavium LLC

CaliforniaCavium (Taiwan) Ltd.

TaiwanCavium Semiconductor Technology (Shanghai) Co., Ltd.

ChinaCavium Networks Singapore PTE. LTD.

SingaporeWWC I, LLC

DelawareBeijing WWCOMS Info Technology Ltd.

ChinaMonta Vista Software Japan, Inc.

JapanMonta Vista Korea

KoreaMonta VistaSoftware Belgium BVBA

BelgiumMonta Vista Software ApS

DenmarkMontaVista Software SAS

FranceMontaVista Software GmbH

GermanyMontaVista Software BV

The NetherlandsMontaVista Software Singapore Pte Ltd.

SingaporeMontaVista Software AB

SwedenMontaVista Software GmbH

SwitzerlandMontaVista MontaVista Software Limited

United Kingdom
**Exhibit 31.1****CEO Certification Pursuant to Rule 13a-14(a)**I, Michael W. Clarke, certify that: 1. I have reviewed this annual report on Form 10-K of Access National Corporation;  2. Based on my knowledge, this report does not contain any untrue statement of amaterial fact or omit to state a material fact necessary to make the statements made, inlight of the circumstances under which such statements were made, not misleading withrespect to the period covered by this report;  3. Based on my knowledge, the financial statements, and other financial informationincluded in this report, fairly present in all material respects the financialcondition, results of operations and cash flows of the registrant as of, and for, theperiods presented in this report;  4. The registrant’s other certifying officer and I are responsible for establishingand maintaining disclosure controls and procedures (as defined in Exchange Act Rules13a-15(e) and 15d-15(e)) for the registrant and have: (a) designed such disclosure controls and procedures, or caused suchdisclosure controls and procedures to be designed under our supervision, toensure that material information relating to the registrant, including itsconsolidated subsidiaries, is made known to us by others within those entities,particularly during the period in which this report is being prepared;  (b) evaluated the effectiveness of the registrant’s disclosure controlsand procedures and presented in this report our conclusions about theeffectiveness of the disclosure controls and procedures, as of the end of theperiod covered by this report based on such evaluation; and  (c) disclosed in this report any change in the registrant’s internalcontrol over financial reporting that occurred during the registrant’s mostrecent fiscal quarter (the registrant’s fourth fiscal quarter in the case of anannual report) that has materially affected, or is reasonably likely tomaterially affect, the registrant’s internal control over financial reporting;and 5. The registrant’s other certifying officer and I have disclosed, based on our mostrecent evaluation of internal control over financial reporting, to the registrant’sauditors and the audit committee of the registrant’s board of directors (or personsperforming the equivalent functions): (a) all significant deficiencies and material weaknesses in the designor operation of internal control over financial reporting which are reasonablylikely to adversely affect the registrant’s ability to record, process, summarizeand report financial information; and  (b) any fraud, whether or not material, that involves management orother employees who have a significant role in the registrant’s internal controlover financial reporting.     Date: March 28, 2006 /s/ Michael W. Clarke      Michael W. Clarke    President and Chief Executive Officer & Director
_______________________________________ __ Michigan Supreme Court 

# Order

Lansing, Michigan

May 27, 2008 Clifford W. Taylor, Chief Justice
135936 Michael F. Cavanagh Elizabeth A. Weaver Marilyn Kelly Maura D. Corrigan PEOPLE OF THE STATE OF MICHIGAN, Plaintiff-Appellee, Robert P. Young, Jr. Stephen J. Markman, Justices

v SC: 135936 COA: 275879 Wayne CC: 06-009052-01 NATASHA LEEANN DENNARD, Defendant-Appellant.

________________ _______________ __________/

On order of the Court, the application for leave to appeal the January 29, 2008 judgment of the Court of Appeals is consid ered, and it is DENIED, because we are not persuaded that the question presented s hould be reviewed by this Court.

l0519 I, Corbin R. Davis, Clerk of the Mi chigan Supreme Cour t, certify that the foregoing is a true and complete copy of the order entered at the direction of the Court.

May 27, 2008

Clerk
Exhibit 32.2





CERTIFICATION PURSUANT TO 18 U.S.C.  SECTION 1350,


AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002*





In connection with the Annual Report of Martin Midstream Partners L.P., a Delaware limited partnership (the “Partnership”), on Form 10-K/A for the year ended December 31, 2017, as filed with the Securities and Exchange Commission (the “Report”), I, Robert D. Bondurant, Chief Financial Officer of Martin Midstream GP LLC, the general partner of the Partnership, certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. Section 1350), that to my knowledge:





(1)          the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and





(2)          the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Partnership.








/s/ Robert D. BondurantRobert D. Bondurant,Chief Financial Officerof Martin Midstream GP LLC,General Partner of Martin Midstream Partners L.P.March 29, 2018





*A signed original of this written statement required by Section 906 has been provided to the Partnership and will be retained by the Partnership and furnished to the Securities and Exchange Commission or its staff upon request.
### Products Excluded from A**ug. 31, 2011 Cancellation Order**

Certain requests to voluntarily cancel pesticide products announced in the January 19, 2011 6(f) Notice, (FRL - 8857 - 1) were omitted from the cancellation order published August 31, 2011 (FRL8885 - 6) because those products were cancelled in a previously published document. These products are listed in the table below. The effective date of cancellation of th e se products was July 15, 2011 as stated in the cancellation order titled: ``Cancellation of Pesticides for Non Payment of Year 2011 Registration Maintenance Fees.'' The cancellation order was published July 27, 2011 (76 FR 44907) (FRL - 8879 - 8) and can be found in docket EPA- HQ - OP P - 2011 - 055 8. **Registration No. Product Name**  **Active Ingredients** 000004 - 00059 Bonide Rose and Flower Dust Malathion Carbaryl Captan 001719 - 00044 Zin - Tox Wo od Preservative Zinc naphthenate
002517 - 00066 Sergeant's Skip Flea & Tick Spray Shampoo Plus Conditioner for Dogs Piperonyl butoxide Permethrin 002829 - 00082 Vin yzene BP - 5 10,10' - Oxy bisphenoxarsine
061282 - 00007 Rami k Meal Rodenticide for Control of Commensal Rats and Mice Diphacinone
WA- 000031 Pear W rap III Copper carbonate, basic Ethoxyquin
WA- 050007 Sencor DF 75% Dry Flowable Herbicide Metribuzin
IN THE SUPREME COURT OF PENNSYLVANIA

In the Matter of

MICHAEL EVAN WEINTRAUB :

:

:

:

:

:

:

:

:

: No. 2625 Disciplinary Docket No. 3

Board File No. C1

- 19

- 468

(Supreme Court of New Jersey, D

- 65 September Term 2018)

Attorney Registration No. 78416

(Out of State)

ORDER

PER CURIAM

AND NOW , this 6 th day of August , 2019, having failed to respond to a Notice and

Order directing him to provide reasons against the imposition of reciprocal discipline,

Michael Evan Weintraub is suspended from the practice of law in th e Commonwealth of

Pennsylvania for six months. He shall comply with all the provisions of Pa.R.D.E. 217.
**OFFICE OF**  **THE ATTORNEY**  **GENERAL OF**  **TEXAS AUSTIN**  

### QROVER SELLERS ATTORNLI QLNCRAL

0 pour rrquort uo auota rrom

Thl8 or **aour**

to, 1044, the 

### l m5ptloa 0r tOaOrr1 menuteeturerel* 0x018* tnrOn trorrlrkr 60 1844, tlrr

@w-b~lmer 

### revoked $k ngulatloa8~8l8Mag k Gx tru ml08 U arti 

### ta the tme of rtdo. a #elitlW ruUltirlr8 thwoot. E. quote the tati br thl8 

### nto~*la (IOtb ran, l pporrr 

### on pa60 

### 1s Ia us84 or 

### Tha VnStUatr~ar 

### Lmf

robll, -Thereromtlo~ l8 l



### fteotilreperontly 

### wltb raoprot to rrtlrlw a016 (I& tnmrwed to a"I rta8e territory et the 

### vnltedSbrtw, polltie ruMir rloa tbrrreoi, or **the** Dlrtrlat et Ooluablr,

### l zorpt thet the rorooatlon rho11 ao6 9 to "'"i,

ma 

### l xoaptlora

### OtMnire rpplleoblowith rrrprot 0 arti 8 a0ia or tmt8rOa ponuana t0 l 00atraot whrbd late prior to mob drto. **TrD.6U~,~ot.e0,1944.~** ws m-aof the e 

### lsloa wema dlrpora or Tour problem ritliiol

ahe oeooroltyof 

### l lrln# late thO oonrtltu$lonrlpaor i **prorwted** 

### by~otu**roquwt.** Tt will be noted that tb* **rrroartlea**0t the 1s~iOti00 

### r0i~tiag t0 t01 tr00 mm, l rr40tir0 Rorombu ItO,

1*44 0ootoS the prorlro that lt rhrlt not rpply to cla 

# l amp~loa othomlrm rppllorblbrlth rergeot to ;r$,~~8016 par8:dat t9 9 

### aqntrrrsoatuo4 late prior to

The h~OiO0 Or mO%a, iu1, OttrOb to ~00r nqttbot, ;hOwr $lut thr da@ @i thr OrhE WW OOtOokr (111, **1944, rd**  th@ l ooontrr.t for tha rrlo 

### ot the btmlmmr maohim 8u l 

### ntuod Mb *;oia to the l rr00th0 art0 

### or the nvowtloa, mid the 

### l

u~~ptlen Of the trx would be rppllo4ble. x0 l

### e returnlly your

### 00~~0r latolar Ho. 5111699, to@har wltb your 

### letterr?oa the Oollootoror Xnterml Rotonuo.

7tJ~MOIl.. KO wu#t the rorsgolng suiflolwtly l8wer# your

Robort 0. Kooh Awl.8 tent

h?PROVBD JAR 80, 1940 Q8Tlo8 a, m$ey Plmn A8smrm ATTOltBBT ll3RBRAL
EX-10.16





 Exhibit 10.16 

 
 



 
 November 12, 2020 

Patrick Jordan 
 Dear Patrick: 

I’m pleased to confirm your transfer to AgenTus Therapeutics, Inc. as Chief Operating Officer reporting to Walter Flamenbaum effective August 31, 2020.
Your annual base salary will be $360,000 less applicable legal deductions, which will be paid at the bi-weekly rate of $13,846.15. In addition, you will be eligible to participate in our annual bonus program with a target bonus of 35% of your base
salary. 
 Subject to approval by the Board of Directors, you will be issued a grant of 20,000 shares of restricted common stock pursuant to the AgenTus
Therapeutics, Inc. 2018 Equity Incentive Plan. With respect to this grant, 10,000 shares will vest in equal annual increments over four years, with 2,500 shares vesting on each of the first, second, third and fourth anniversary of August 31, 2020.
The remaining 10,000 shares will be subject to milestone-based vesting, and shall vest in a single tranche upon the closing of an AgenTus private equity financing round of at least $30 million on or before December 31, 2021 and in advance of any
initial public offering. The equity awards of Agenus Inc. that you currently hold will continue to vest in accordance with their terms so long as you remain an employee of AgenTus. 

As part of your employment with AgenTus, you have and will be exposed to, and provided with, valuable confidential and/or trade secret information concerning
the Company, its affiliates and its present and prospective clients. As a result, in order to protect the Company’s legitimate business interests, you agree, as a condition of your employment, to enter into our standard form Employee
Non-Disclosure Agreement. This document is enclosed for your review and execution by the first day of your employment. In addition, please understand that all employment with AgenTus is on an “at will” basis. This letter does not
constitute a contract of employment for a specific term. 
 The provisions of this offer letter supersede all prior oral and written offers, communications,
agreements and understandings between AgenTus and you with respect to the subject matter of this letter. 
 By signing below, you acknowledge, understand
and agree that immediately upon your start of employment with AgenTus, your employment with Agenus Inc. will automatically and immediately terminate. If you accept this offer, please kindly return this signed letter to Human Resources by November
15, 2020. 
  

	
	Yours sincerely,
	
	 /s/ Walter Flamenbaum

	 Walter Flamenbuam

	 Chief Executive Officer, AgenTus


 I accept your offer of employment as outlined in this letter.

 

							
	/s/ Patrick Jordan	 		 	11/12/2020	 	  

	Signature	 		 	Date	 	


3 Forbes Road, Lexington, MA 02421     T: 781.674.4400     F: 
781.674.4200     www.agentustherapeutics.com
AVS

Quality Management

System

Title: Domestic New Action Worksheet with 56

QPM#

AIR-ANM-030-F7

Date: December 17, 2008

Revision

1

Record of Contacts

:JOII-OOSLj

FDMS Docket No. FAA-.20tr__ - _

With whom outside the FAA has this proposal been discussed (c.g .• AlA, RAA, ALPA, elc.)?

Org~niZllt;on Person Conlarled Date

;\'1'.-\, (;I'cg Hllrd)' - Cabin IFF ARIDER 5/28/2009

AT!\. NguYl'n, Rene T - Cabill IFE ,\IVl)J<:R 5/18JZUU')

I

Organization Persoll C(lntactcd I Date

UNCONTROLLED COPY WHEN DOWNLOADED

Check the Masler US! to Verily llIal This is the Coned Revision Belom Use
**Exhibt 31.2**CERTIFICATIONI, Arthur D. Chadwick, Chief Financial Officer of Cavium Networks, Inc., certify that:1.     I have reviewed this annual report on Form 10-K of Cavium Networks, Inc.;2.     Based on my knowledge, this report does not contain any untrue statement of a material fact oromit to state a material fact necessary to make the statements made, in light of the circumstancesunder which such statements were made, not misleading with respect to the period covered by thisreport;3.     Based on my knowledge, the financial statements, and other financial information included inthis report, fairly present in all material respects the financial condition, results of operationsand cash flows of the registrant as of, and for, the periods presented in this report;4.     The registrant’s other certifying officer(s) and I are responsible for establishing andmaintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and15d-15(e)) for the registrant and have:(a) Designed such disclosure controls and procedures, or caused such disclosure controls andprocedures to be designed under our supervision, to ensure that material information relating tothe registrant, including its consolidated subsidiaries, is made known to us by others within thoseentities, particularly during the period in which this report is being prepared;(b) Evaluated the effectiveness of the registrant’s disclosure controls and procedures andpresented in this report our conclusions about the effectiveness of the disclosure controls andprocedures, as of the end of the period covered by this report based on such evaluation; and(c) Disclosed in this report any change in the registrant’s internal control over financialreporting that occurred during registrant’s most recent fiscal quarter (the registrant’s fourthquarter in the case of an annual report) that has materially affected, or is reasonably likely tomaterially affect, the registrant’s internal control over financial reporting.5.     The registrant’s other certifying officer(s) and I have disclosed, based on our most recentevaluation of internal control over financial reporting, to the registrant’s auditors and the auditcommittee of registrant’s board of directors (or persons performing the equivalent functions):(a) All significant deficiencies and material weaknesses in the design or operation of internalcontrol over financial reporting which are reasonably likely to adversely affect the registrant’sability to record, process, summarize and report financial information; and(b) Any fraud, whether or not material, that involves management or other employees who have asignificant role in the registrant’s internal control over financial reporting.     Date: March 10, 2008             /s/ Arthur D. Chadwick     Arthur D. Chadwick  Chief Financial Officer
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report of Cytation Corporation (the "Company") on Form 10QSB for the period ending March 31, 2004 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Kevin J. High, President and Acting Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1)  The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and 
     (2)  The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



/s/Kevin J. High                               Kevin J. High
President and Chief Financial Officer
May 13, 2004